Replies to post #105653 on Anavex Life Sciences Corp (AVXL)

[NWDR]

I am very long.

I am very confident that A2-73 has a positive effect on mental state of people suffering from a variety of CNS diseases.

How come I'm confident in this? Primarily one huge readout from the current trial that McMagyar keeps pointing out. The elimination of sleep problems for all patients who had reported sleep issues when they entered the trial. My mother has suffered from mental illness (schizophrenia, paranoia) for the past 50 years. When I was young my mom would roam the house at all hours of the night. Even now, with much better medication, I have firm instructions with the med aids at her assisted living facility to let me know immediately if my mom is up real early in the AM and wandering around the facility. Her lack of sleep is the first indication that something is slipping and she needs attention.

I think Anavex could run a trial looking only for a reduction in sleep issues in patients who have CNS diseases and get approved solely due to the improved sleep.

I am becoming much more confident and comfortable in Dr. Chris Missling's leadership and ability to get A2-73 approved over the past year. Ex FDA executive hire, notice of allowance for A2-73 plus donepezil patent, many foundations looking very interested in A2-73, etc.. I want the executives of a small co. I'm invested in too spend their time getting the word out, getting patent protection, getting financing at reasonable terms, hiring key individuals to fill important gaps in the companies ranks, getting the MDs and scientists on-board, move the science forward with pre-clinical data, have lots of skin in the game for potential gain and NOT be selling shares already granted and finally have the right trials (properly designed) started at the right time. I don't care to see a small co. PR every time their CEO flies to a conf or supposedly communicates with the FDA. If Anavex put out a PR that stated the CEO was going to speak at an Epilepsy conference and that the co. was in discussions with the FDA on trial design for Epilepsy I would state, "So what." Why spend time on a PR that really says nothing other than I'm doing my job. I think Dr. Missling has decided to not PR any data until he has everything that he wants in place. You either trust him or you don't. I happen to trust him. Simple as that.

Go AVXL